Type 2 Diabetes Clinical Trials in Jacksonville, Florida

5 studies are recruiting for type 2 diabetes in Jacksonville, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

   This study aims to find out whether a study medicine called survodutide helps people control their blood sugar. Adults who live with type 2 diabetes and with a body mass index (BMI) of 23 kg/m2 or higher can join. The study has 3 parts. In each part the study compares survodutide with placebo. Surv…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Northeast Research Institute, Jacksonville, Florida

   Locations

   121 in total

   Run by

   Boehringer Ingelheim

   See if you can join NCT07754461 on ClinicalTrials.gov

2. AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

   This study is being conducted to find out how well zenagamtide works and how safe it is compared to insulin glargine in participants with type 2 diabetes who are at higher risk of heart and blood vessel problems and are already taking 1 to 3 diabetes medications. There are 2 study treatments in thi…

   Stage

   Phase 3

   Ages

   45 and older

   Site

   East Coast Institute For Research, Jacksonville, Florida

   Locations

   330 in total

   Run by

   Novo Nordisk A/S

   See if you can join NCT07797335 on ClinicalTrials.gov

3. A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

   This clinical study is testing how the study medicine CagriSema helps people living with obesity, with or without type 2 diabetes (T2D), lose weight. The purpose of the study is to find out how safe and effective CagriSema is for body weight loss in these participants. Participants will receive eit…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Northeast Research Institute, Jacksonville, Florida

   Locations

   303 in total

   Run by

   Novo Nordisk A/S

   See if you can join NCT07564414 on ClinicalTrials.gov

4. A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

   The purpose of this study is to identify and characterize patients with known Type 2 Diabetes Mellitus (T2DM) for possible participation in ongoing or future T2DM clinical studies, and to characterize trends in key concomitant medication use in this patient population across different geographical …

   Stage

   Not phased

   Ages

   18 and older

   Site

   Research Site, Jacksonville, Florida

   Locations

   76 in total

   Run by

   AstraZeneca

   See if you can join NCT07606066 on ClinicalTrials.gov

5. A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

   The main purpose of this study is to evaluate additional dosing options for dulaglutide in pediatric participants with Type 2 Diabetes. Participation in this study will last about 8 months.

   Stage

   Phase 3

   Ages

   10 to 17

   Site

   Nemours Children's Health, Jacksonville, Florida

   Locations

   51 in total

   Run by

   Eli Lilly and Company

   See if you can join NCT06739122 on ClinicalTrials.gov